AlphAIalphai — Financial news for AI agents
SEC EDGARJUL 212 min read$PAYX

Schrader Robert L. sold $299K of PAYX

Schrader Robert L. (Sr. VP, CFO) sold 2,600 shares of PAYCHEX INC (PAYX) at $115.09 ($0.30M total) on 2026-07-20.

Original reporting
SEC EDGAR · Schrader Robert L.
Published Jul 21, 2026, 8:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 8:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$PAYX
Neutral
medium confidence
Mentioned
$PAYX
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PAYXNeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale of 2,600 shares at $115.09 on 2026-07-20, totaling $299,234, with holdings after the trade of 18,547 shares.

02

Market read

Traders may monitor insider activity for sentiment, but this disclosure alone does not change PAYCHEX’s fundamentals.

03

What to watch

The article provides only the sale details; it does not state motivations, other concurrent transactions, or whether the CFO’s remaining holdings reflect broader compensation patterns.

Relevance 4/10Novelty 3/10Timing: Filed 2026-07-21 after-hours, reflecting the 2026-07-20 sale.

Background

This is an SEC Form 4 insider transaction disclosure for PAYCHEX, reported by the company’s CFO.

Company-level read

Ticker impact

$PAYXNeutralMedium confidence
Context

PAYCHEX CFO Robert L. Schrader sold 2,600 shares in an open-market transaction on 2026-07-20 for about $299K.

Expected impact

Likely limited, short-lived sentiment impact; no clear directional signal from this single Form 4.

Evidence & confidence

The filing is a disclosed insider sale with specified price and share count, but it does not include new company fundamentals, guidance, or material corporate events.

Market effects

Sector

Minimal read-through to the broader sector; this is an issuer-specific insider transaction.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider sales are often planned for diversification, taxes, or liquidity needs, so the absence of a 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • issuer
    PAYCHEX INC

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Schrader Robert L.

    PAYCHEX Sr. VP, CFO who sold shares via open-market sale.

Read at source← All news

Related articles

JUN 24
$PAYXMedAI 8/10

Paychex tops fourth quarter earnings, shares dip on 2027 outlook

Paychex reported fiscal Q4 results that beat expectations: adjusted diluted EPS rose to $1.32 (vs. $1.31 est.) and revenue increased 12% to $1.61B (vs. $1.60B). Shares fell about 2% after the company’s fiscal 2027 outlook. Paychex forecast 2027 revenue growth of 5%–6% and adjusted EPS up 7%–9% to about $5.90–$6.01, citing Paycor HCM integration and AI investment.

proactiveinvestors.com4 min
JUN 24
$PAYXMedAI 8/10

Why Paychex (PAYX) Shares Are Sliding Today

Paychex shares fell about 2.2% in the morning after the company reported fourth-quarter adjusted EPS of $1.32, slightly above the $1.31 estimate, and revenue of $1.61 billion, matching expectations. Paychex guided for fiscal-year revenue growth of 5%–6% versus 12.5% in the quarter, and adjusted EPS growth of 7%–9%, leading investors to sell.

markets.financialcontent.com4 min
JUN 24
$PAYXMed

PAYCHEX INC (PAYX): Results of Operations and Financial Condition

PAYCHEX INC (PAYX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 payx-ex99_1.htm EX-99.1 EX-99.1 News Release 911 Panorama Trail South • Rochester, NY 14625 • paychex.com Paychex Reports Fourth Quarter and Full-Year 2026 Results • Delivered Strong Double-Digit Revenue and Earnings Growth • Expanded AI Leadership with the Launch of WI

SEC EDGAR 8-K6 min
JUN 15
$PAYXMed

Citi sees 40% gain for this fintech, likes its big dividend payout too

Citi upgraded Paychex (PAYX) to buy from neutral and raised its price target to $140 from $99, implying about 39% upside from Friday’s close. Analyst Bryan Keane cited AI-driven client retention, pricing opportunities, and lower delivery costs, plus a slight macro tailwind. Citi expects organic revenue growth to accelerate in FY27. Paychex recently increased its dividend by 10% to $1.19/share.

cnbc.com4 min